Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Prevalence of anxiety and depression symptoms in pregnant women with type 2 diabetes and the impact on glycaemic control

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{4b5257106d76453ead994f910f7943a2,
title = "Prevalence of anxiety and depression symptoms in pregnant women with type 2 diabetes and the impact on glycaemic control",
abstract = "AIMS: To study the prevalence of anxiety and depression symptoms in pregnant women with type 2 diabetes compared with pregnant women without diabetes. Secondly, to explore whether anxiety and/or depression symptoms in early pregnancy have an impact on glycaemic control and gestational weight gain.METHODS: A prospective cohort study of 90 consecutive singleton pregnant women with type 2 diabetes and 88 singleton pregnant women without diabetes. All women completed the Hospital Anxiety and Depression Scale questionnaire in early and late pregnancy. A score ≥8 in the anxiety or the depression scale was used to define anxiety and/or depression symptoms.RESULTS: Anxiety and/or depression symptoms were present in 40% of women with type 2 diabetes and 7% of women without diabetes in early pregnancy (Relative Risk=5.87 (95% Confidence Interval: 2.60-13.22). The figures were similar in late pregnancy. In women with type 2 diabetes and anxiety and/or depression symptoms in early pregnancy, HbA1c (mean±SD) was 52±14 vs. 49±11 mmol/mol (6.9±1.2 vs. 6.6±1.0%), p=0.31 in early pregnancy and 43±8 vs. 40±4 mmol/mol (6.1±0.7 vs. 5.8±0.4%), p=0.04 in late pregnancy compared with women without symptoms. Gestational weight gain was similar in both groups.CONCLUSIONS: In women with type 2 diabetes, 40% had anxiety and/or depression symptoms in early pregnancy. Women with these symptoms obtained less optimal glycaemic control in late pregnancy but similar gestational weight gain as the remaining women.",
keywords = "pregnancy, anxiety, depression, gestational weight gain, pregnancy outcome, type 2 diabetes",
author = "Bj{\"o}rg {\'A}sbj{\"o}rnsd{\'o}ttir and Marianne Vestgaard and Do, {Nicoline C} and Lene Ringholm and Andersen, {Lise L T} and Jensen, {Dorte M} and Peter Damm and Mathiesen, {Elisabeth R}",
note = "{\textcopyright} 2020 Diabetes UK.",
year = "2021",
doi = "10.1111/dme.14506",
language = "English",
volume = "38",
pages = "e14506",
journal = "Diabetic Medicine",
issn = "1464-5491",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "3",

}

RIS

TY - JOUR

T1 - Prevalence of anxiety and depression symptoms in pregnant women with type 2 diabetes and the impact on glycaemic control

AU - Ásbjörnsdóttir, Björg

AU - Vestgaard, Marianne

AU - Do, Nicoline C

AU - Ringholm, Lene

AU - Andersen, Lise L T

AU - Jensen, Dorte M

AU - Damm, Peter

AU - Mathiesen, Elisabeth R

N1 - © 2020 Diabetes UK.

PY - 2021

Y1 - 2021

N2 - AIMS: To study the prevalence of anxiety and depression symptoms in pregnant women with type 2 diabetes compared with pregnant women without diabetes. Secondly, to explore whether anxiety and/or depression symptoms in early pregnancy have an impact on glycaemic control and gestational weight gain.METHODS: A prospective cohort study of 90 consecutive singleton pregnant women with type 2 diabetes and 88 singleton pregnant women without diabetes. All women completed the Hospital Anxiety and Depression Scale questionnaire in early and late pregnancy. A score ≥8 in the anxiety or the depression scale was used to define anxiety and/or depression symptoms.RESULTS: Anxiety and/or depression symptoms were present in 40% of women with type 2 diabetes and 7% of women without diabetes in early pregnancy (Relative Risk=5.87 (95% Confidence Interval: 2.60-13.22). The figures were similar in late pregnancy. In women with type 2 diabetes and anxiety and/or depression symptoms in early pregnancy, HbA1c (mean±SD) was 52±14 vs. 49±11 mmol/mol (6.9±1.2 vs. 6.6±1.0%), p=0.31 in early pregnancy and 43±8 vs. 40±4 mmol/mol (6.1±0.7 vs. 5.8±0.4%), p=0.04 in late pregnancy compared with women without symptoms. Gestational weight gain was similar in both groups.CONCLUSIONS: In women with type 2 diabetes, 40% had anxiety and/or depression symptoms in early pregnancy. Women with these symptoms obtained less optimal glycaemic control in late pregnancy but similar gestational weight gain as the remaining women.

AB - AIMS: To study the prevalence of anxiety and depression symptoms in pregnant women with type 2 diabetes compared with pregnant women without diabetes. Secondly, to explore whether anxiety and/or depression symptoms in early pregnancy have an impact on glycaemic control and gestational weight gain.METHODS: A prospective cohort study of 90 consecutive singleton pregnant women with type 2 diabetes and 88 singleton pregnant women without diabetes. All women completed the Hospital Anxiety and Depression Scale questionnaire in early and late pregnancy. A score ≥8 in the anxiety or the depression scale was used to define anxiety and/or depression symptoms.RESULTS: Anxiety and/or depression symptoms were present in 40% of women with type 2 diabetes and 7% of women without diabetes in early pregnancy (Relative Risk=5.87 (95% Confidence Interval: 2.60-13.22). The figures were similar in late pregnancy. In women with type 2 diabetes and anxiety and/or depression symptoms in early pregnancy, HbA1c (mean±SD) was 52±14 vs. 49±11 mmol/mol (6.9±1.2 vs. 6.6±1.0%), p=0.31 in early pregnancy and 43±8 vs. 40±4 mmol/mol (6.1±0.7 vs. 5.8±0.4%), p=0.04 in late pregnancy compared with women without symptoms. Gestational weight gain was similar in both groups.CONCLUSIONS: In women with type 2 diabetes, 40% had anxiety and/or depression symptoms in early pregnancy. Women with these symptoms obtained less optimal glycaemic control in late pregnancy but similar gestational weight gain as the remaining women.

KW - pregnancy

KW - anxiety

KW - depression

KW - gestational weight gain

KW - pregnancy outcome

KW - type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85099047883&partnerID=8YFLogxK

U2 - 10.1111/dme.14506

DO - 10.1111/dme.14506

M3 - Journal article

C2 - 33368557

VL - 38

SP - e14506

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 1464-5491

IS - 3

M1 - e14506

ER -

ID: 61613535